Wednesday was a good day for American stocks generally, but it was even sunnier for Eli Lilly (NYSE: LLY) . The pharmaceutical giant won regulatory approval for a product that's bound to be very popular, and investors rewarded the company by pushing its stock nearly 4% higher on the day. That crushed the S&P 500 index's 0.7% gain. Before market open, Eli Lilly announced that the U.S. Food and Drug...
Wednesday was a good day for American stocks generally, but it was even sunnier for Eli Lilly (NYSE: LLY) . The pharmaceutical giant won regulatory approval for a product that's bound to be very popular, and investors rewarded the company by pushing its stock nearly 4% higher on the day. That crushed the S&P 500 index's 0.7% gain. Before market open, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) approved its Foundayo weight-loss product. What makes this groundbreaking for the company is that Foundayo is a daily pill. The pharmaceutical titan's first approved weight-loss drug, the popular Zepbound, is delivered by injection once per week. The two also use different molecules to do their work. Image source: Getty Images. Continue reading
Arsenal lose the second leg of their quarter-final against Chelsea 1-0 at Stamford Bridge, but win 3-2 on aggregate to reach the semi-finals of the Women's Champions League and move a step closer to successfully defending their title.
Arsenal lose the second leg of their quarter-final against Chelsea 1-0 at Stamford Bridge, but win 3-2 on aggregate to reach the semi-finals of the Women's Champions League and move a step closer to successfully defending their title.
Jon Tetzlaff Boeing ( BA ) won a contract worth up to $900M to support and maintain T-38C avionics, boosting long-term revenue visibility. Work will be carried out across multiple U.S. Air Force bases and is expected to be completed by March 31, 2036. About $56.2M in FY2026 funds will be obligated at the time of award, with the Air Force Life Cycle Management Center being the contracting authority...
Jon Tetzlaff Boeing ( BA ) won a contract worth up to $900M to support and maintain T-38C avionics, boosting long-term revenue visibility. Work will be carried out across multiple U.S. Air Force bases and is expected to be completed by March 31, 2036. About $56.2M in FY2026 funds will be obligated at the time of award, with the Air Force Life Cycle Management Center being the contracting authority. More on Boeing Boeing Vs. Airbus: The Iran War Shock And The Production Reality Boeing: The Triple Blow Boeing: Ignore Fuel Price Spikes For This Decade Play Boeing supply chain shows signs of stabilization as 737 output trails target: BNP Paribas Pentagon expands missile supply chain with plan to triple Patriot seeker output
(RTTNews) - The U.S. Food and Drug Administration has given the green light to Foundayo, a new daily weight-loss pill from Eli Lilly and Company, which shakes things up in the obesity treatment market.
(RTTNews) - The U.S. Food and Drug Administration has given the green light to Foundayo, a new daily weight-loss pill from Eli Lilly and Company, which shakes things up in the obesity treatment market.
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.72%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.18%. June E-mini S&P futures (ESM26 ) rose +0.74%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.72%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.18%. June E-mini S&P futures (ESM26 ) rose +0.74%, and June E-mini Nasdaq futures...
anouchka/iStock Unreleased via Getty Images Starbucks Corp. ( SBUX ), the world's largest coffee-shop chain, showed signs of a top-line recovery that fueled a February rally, but the fundamental picture remains bleak. A soft rebound in revenue has come at the expense of profit margins, offering little justification for the stock’s rich valuation. Considering both fundamental and macro headwinds, I...
anouchka/iStock Unreleased via Getty Images Starbucks Corp. ( SBUX ), the world's largest coffee-shop chain, showed signs of a top-line recovery that fueled a February rally, but the fundamental picture remains bleak. A soft rebound in revenue has come at the expense of profit margins, offering little justification for the stock’s rich valuation. Considering both fundamental and macro headwinds, I initiate coverage with a sell rating and a price target of $42.40, which implies a potential downside of about 50%. With skepticism of a sustained recovery, I apply a 20x forward earnings multiple versus ~39x currently traded. Margin squeeze The company eked out 4% comparable sales growth in the latest quarter, including a 3% transaction increase and a 1% average ticket gain. CEO Brian Niccol, who previously steered the successful turnaround of restaurant chain Chipotle Mexican Grill ( CMG ), has implemented the “ Back to Starbucks ” strategy to improve service and cut wait times. However, rising costs are making this strategy less sustainable. Gross margin shrank to 21.1% in 1Q26, which ended December 2025, from 24.5% a year ago, while operating margin similarly compressed by 290 bps to 9%. Bloated labor costs, driven by more baristas and their training, and higher tech spend to streamline operations have put a squeeze on profitability. As a result, adjusted EPS dropped 19% YoY to 56 cents in the quarter. A sharp decline in GAAP-based earnings was largely attributable to the reclassification of SBUX’s China assets following a stake sale, which led to a surge in recorded tax liabilities. Company filings While the company guides for a 3%-plus increase in 2026 comparable revenue, along with a slight improvement in operating margin, I doubt both goals are achievable at the same time. They can’t have the cake and eat it. For FY26, which ends September 2026, I expect adjusted EPS to stay flat at $2.12, below the low end of SBUX’s guidance range ($2.15-$2.40). Macro headwinds Ex...
PhonlamaiPhoto/iStock via Getty Images The Trump administration is preparing to reshape its steel and aluminum tariff regime by altering duties on finished products to help simplify compliance, in an order that could be announced as soon as this week, The Wall Street Journal reported Wednesday. According to the report , f inished products made with imported steel and aluminum would be tariffed at ...
PhonlamaiPhoto/iStock via Getty Images The Trump administration is preparing to reshape its steel and aluminum tariff regime by altering duties on finished products to help simplify compliance, in an order that could be announced as soon as this week, The Wall Street Journal reported Wednesday. According to the report , f inished products made with imported steel and aluminum would be tariffed at 25%, which would apply to the entire value of a finished product—known derivative products—containing steel and aluminum, replacing the current 50% tariff, which only applies to the value of steel or aluminum used in a product. The 50% tariff would remain in place for commodity-grade steel and aluminum products, which are almost entirely made of the metals, the report said. The consequences of the tariff changes would vary depending on the product, WSJ reported, as the tariff rate would be lower for many goods, but the change also could mean the cost of the tariffs assessed on many products would be higher because of duties being charged on the full value of imported products rather than just their steel or aluminum content. Potentially relevant steel and aluminum stocks include Nucor ( NUE ), Cleveland-Cliffs ( CLF ), Steel Dynamics ( STLD ), Commercial Metals ( CMC ), Reliance ( RS ), ArcelorMittal ( MT ), Alcoa ( AA ), Century Aluminum ( CENX ), Kaiser Aluminum ( KALU ), Constellium ( CSTM ). More on steel and aluminum stocks Alcoa Has A Lot Going For It That Justifies Further Upside Nucor: Tariff Turmoil Is Why You Stick With High Quality Steel Producers Steel Dynamics: Verdict Is Still Out On Trump Tariffs Issue
Woods focusing on his health and wellbeing after crash Florida judge grants his request to leave the US Tiger Woods has turned down the opportunity to captain the United States at the 2027 Ryder Cup, the PGA of America has announced. The former world No 1’s decision comes after he announced he would step away from golf for a period to focus on his health and wellbeing. Woods was charged with drivi...
Woods focusing on his health and wellbeing after crash Florida judge grants his request to leave the US Tiger Woods has turned down the opportunity to captain the United States at the 2027 Ryder Cup, the PGA of America has announced. The former world No 1’s decision comes after he announced he would step away from golf for a period to focus on his health and wellbeing. Woods was charged with driving under the influence after being involved in a car accident last week. Continue reading...
Nvidia (NASDAQ: NVDA) has made many big moves in recent years, from launching the most powerful artificial intelligence (AI) chips and systems to becoming the first company to reach $4 trillion in market capitalization. The tech giant wisely identified the potential AI opportunity about a decade ago and set its sights on dominating the market. And this was the key move to unlock success. Nvidia's ...
Nvidia (NASDAQ: NVDA) has made many big moves in recent years, from launching the most powerful artificial intelligence (AI) chips and systems to becoming the first company to reach $4 trillion in market capitalization. The tech giant wisely identified the potential AI opportunity about a decade ago and set its sights on dominating the market. And this was the key move to unlock success. Nvidia's AI dreams came true, as it built out a complete AI portfolio including chips, networking tools, and more, and expanded its reach into a broad range of industries -- from healthcare to automotive. All of this has translated into enormous levels of revenue and profit. Stock performance followed, with Nvidia's shares soaring 500% over the past three years. But these days, Nvidia stock is struggling along with other stocks that earlier led market gains. These AI stocks and other growth players have fallen out of favor, at least temporarily, in today's tough market environment. And against this backdrop, Nvidia stock just did something for the first time in 13 years. Here's what history says may happen next... Continue reading
The geopolitical conflict in the Middle East has disrupted global energy markets, driving up oil and natural gas prices. That will directly benefit energy companies like Diamondback Energy (NASDAQ: FANG) , Devon Energy (NYSE: DVN) , and Chevron (NYSE: CVX) . They will probably be strong performers throughout 2026, given the nature of the oil market. Here's what you need to know. It isn't uncommon ...
The geopolitical conflict in the Middle East has disrupted global energy markets, driving up oil and natural gas prices. That will directly benefit energy companies like Diamondback Energy (NASDAQ: FANG) , Devon Energy (NYSE: DVN) , and Chevron (NYSE: CVX) . They will probably be strong performers throughout 2026, given the nature of the oil market. Here's what you need to know. It isn't uncommon for geopolitical conflicts to drive up energy prices. So, in some ways, what is transpiring in the Middle East has had a fairly predictable outcome on commodity markets. However, it is also important to understand that the end of the conflict won't instantly fix the supply disruptions that have impacted global energy prices. Image source: Getty Images. Continue reading